Quantum physics is no longer confined to cryogenic chips and vacuum chambers. It is starting to seep into the machinery of ...

This article explores how next-generation vaccines are expanding beyond infectious disease to target chronic conditions while ...

SHERLOCK, a rapid CRISPR-based diagnostic, detects Candida auris and antifungal resistance mutations in patient samples in under an hour.

Infection with the pathogenic yeast fungus Candida auris (C. auris) can wreak havoc on the health of hospital patients and ...

The global DNA methylation market size was valued at US$ 1.9 Bn in 2025 and is projected to reach US$ 7.7 Bn by 2036, growing ...

The FDA designates ARB1002 as an orphan drug, highlighting its potential as a novel treatment for pancreatic cancer amid ...

Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the, "Next-Generation ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...

Brisbane-based biotech company Vaxxas has appointed veteran pharmaceutical industry leader David Peacock as its new CEO as it moves to commercialise its needly free vaccination technology. Mr Peacock ...

The software firm has again been recognized as one of the 100 Best Large Places to Work in Chicago by Built In We are ...